Pressure Group Undaunted By EU Refusal To Disclose COVID-19 Vaccine Contracts

Corporate Europe Observatory Cites Overriding Public Interest

The European Commission has dismissed attempts by pressure groups to secure access to details of COVID-19 vaccine deals negotiated with pharmaceutical firms. The Corporate Europe Observatory says it is “disappointed” by the decision but is not giving up the chase.

The European Commission has denied a request for access to the contract it has signed with AstraZeneca PLC for the purchase of COVID-19 vaccines on the grounds that disclosure of the documents could “potentially damage the competitive position of the company” as well as the ongoing vaccine procurement procedures.

The request was filed with the commission’s secretariat general by Olivier Hoedeman of the transparency lobbying group, Corporate Europe Observatory...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography